Medication info
Kaycontin Sustained Release Tablets (Potassium Chloride)

Kaycontin Sustained Release Tablets (Potassium Chloride)

Prescription medicationTablet
Ingredient · strength
Potassium Chloride›600mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
A round tablet with a light orange color.
Packaging
200 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200001783 · Approved 2000.05.26 · Insurance code 645905140

Summary

Main use
Treatment of hypokalemia and digitalis toxicity
Who uses it
Adults
Adult dosage
1. Treatment dose: The usual adult dose is 1,200~3,000mg of potassium chloride daily, divided as appropriate. 2. Preventive dose: Patients receiving diuretics should take 600mg of this medicine once daily. Take immediately after meals. Do not chew or crush. (Injection) The usual adult dose is 0.5~3g of potassium chloride, diluted in Ringer’s solution, glucose injection, or normal saline injection to a concentration of 0.3% (40 mEq as potassium) or less, and administered by intravenous infusion over at least 4 hours at a rate of 8mL per minute or less. The daily dose should not exceed 7.5g of this medicine (100 mEq as potassium). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypokalemia and digitalis toxicity

  • Hypokalemia
  • digitalis toxicity
View approved original text

This medication is used to treat hypokalemia, especially hypokalemia that occurs after taking diuretics. It also helps improve symptoms caused by digitalis toxicity. It is effectively used for both conditions, contributing to the stabilization of the patient's condition.

Dosage and Administration

Adult dosage

1. Treatment dose: The usual adult dose is 1,200~3,000mg of potassium chloride daily, divided as appropriate. 2. Preventive dose: Patients receiving diuretics should take 600mg of this medicine once daily. Take immediately after meals. Do not chew or crush. (Injection) The usual adult dose is 0.5~3g of potassium chloride, diluted in Ringer’s solution, glucose injection, or normal saline injection to a concentration of 0.3% (40 mEq as potassium) or less, and administered by intravenous infusion over at least 4 hours at a rate of 8mL per minute or less. The daily dose should not exceed 7.5g of this medicine (100 mEq as potassium). Adjust the dose and infusion rate as appropriate according to age, body weight, and symptoms.

Precautions

This medication should not be taken by patients with severely impaired kidney function, adrenal function issues, acute dehydration, or extensive tissue damage. Patients with hyperkalemia, gastrointestinal issues, or those who have experienced allergic reactions to this medication's ingredients should also avoid this drug. During treatment, this medication should not be taken together with specific diuretics or anti-aldosterone agents that can increase potassium levels in the body. Since it contains color additive Yellow No. 5, patients allergic to this component should take it with caution. Patients with reduced kidney function or heart disease, individuals with a history of peptic ulcers, and those taking specific medications should consult a doctor or pharmacist before use. Pregnant women should only take this medication when the therapeutic benefits are judged to outweigh the risks, and caution is also recommended for children and the elderly. If symptoms such as vomiting, severe abdominal pain, gastrointestinal bleeding, hives, or heart irregularities occur during treatment, discontinue use immediately and consult a professional. Long-term use requires regular monitoring of potassium levels in the blood, kidney function, and changes in electrocardiograms; if hyperkalemia occurs, use should be discontinued immediately. This medication may cause ulcers if it remains in the esophagus for a long time, so it should be taken with sufficient water, especially avoiding use just before sleep. In case of overdose, serious heart and neuromuscular problems may occur, thus attention to hyperkalemia symptoms is necessary, and appropriate treatment should be sought if needed.

Side effects

  • Abdominal pain
  • severe vomiting
  • abdominal distension
  • gastrointestinal bleeding
  • nausea
  • abdominal discomfort
  • diarrhea
  • gastrointestinal obstruction
  • ulcer
  • perforation
Show 14 more
  • electrocardiogram abnormalities
  • urticaria
  • rash
  • itching
  • hypotension
  • shock
  • ventricular arrhythmia
  • block of each type
  • cardiac arrest
  • sensory disturbances
  • convulsions
  • areflexia
  • respiratory paralysis
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that can block light. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain the drug's efficacy.

Appearance and packaging

Appearance

A round tablet with a light orange color.

Package unit

200 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.